These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3409945)
21. Primary chemosensitivity and secondary drug resistance of xenografted soft part sarcomas. Budach V; Budach W; Scheulen M; Czeglarski G Strahlenther Onkol; 1989 Jul; 165(7):535-6. PubMed ID: 2473534 [No Abstract] [Full Text] [Related]
22. Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysis. Dombernowsky P; Mouridsen H; Schütte J; Santoro A; Rouessé J; Somers R; Stewart W; Pinedo HM; von Oosterom A; Blackledge G Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S17. PubMed ID: 3815714 [No Abstract] [Full Text] [Related]
23. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapy of soft tissue sarcoma--a clinical evaluation of treatment over ten years. Wall N; Starkhammar H Acta Oncol; 2003; 42(1):55-61. PubMed ID: 12665332 [TBL] [Abstract][Full Text] [Related]
25. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients. Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417 [TBL] [Abstract][Full Text] [Related]
26. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone. Demetri GD Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444 [TBL] [Abstract][Full Text] [Related]
27. The role of ifosfamide in paediatric soft tissue sarcomas. de Kraker J; Voûte PA Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S23-4. PubMed ID: 3815716 [TBL] [Abstract][Full Text] [Related]
31. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center]. Roguin A; Ben Arush MW; Higasi A; Kuten A Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870 [TBL] [Abstract][Full Text] [Related]
32. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Benjamin RS; Legha SS; Patel SR; Nicaise C Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S174-9. PubMed ID: 8453693 [TBL] [Abstract][Full Text] [Related]
33. [Value of neoadjuvant radiochemotherapy in undifferentiated soft tissue sarcomas]. Stuschke M Strahlenther Onkol; 1994 Aug; 170(8):480-3. PubMed ID: 8085215 [No Abstract] [Full Text] [Related]
34. [Clinical experience with the cytostatic drug ifosfamide]. Ritter S; Schröder HJ Med Welt; 1977 Sep; 28(35):1395-1400. PubMed ID: 70737 [No Abstract] [Full Text] [Related]
35. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen. Schütte J; Kellner R; Seeber S Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697 [TBL] [Abstract][Full Text] [Related]
37. A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma. Cantwell BM; Carmichael J; Ghani S; Harris AL Cancer Chemother Pharmacol; 1988; 21(1):49-52. PubMed ID: 3124971 [TBL] [Abstract][Full Text] [Related]
38. A phase I-II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcoma. Mansi JL; Fisher C; Wiltshaw E; MacMillan S; King M; Stuart-Harris R Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1439-43. PubMed ID: 3181268 [TBL] [Abstract][Full Text] [Related]
39. Ifosfamide in soft tissue sarcoma. Zaidi SH; Iqbal Z; Mallick JA J Pak Med Assoc; 1990 Sep; 40(9):222-4. PubMed ID: 2123272 [No Abstract] [Full Text] [Related]
40. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]